PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-EFFECTIVE TREATMENT OF AGE-RELATED MACULA DEGENERATION (AMD) IN THE GERMAN HEALTH CARE SYSTEM
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65237-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)65237-0/fulltext
Title :
PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-EFFECTIVE TREATMENT OF AGE-RELATED MACULA DEGENERATION (AMD) IN THE GERMAN HEALTH CARE SYSTEM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65237-0&doi=10.1016/S1098-3015(10)65237-0
First page :
Section Title :
Open access? :
No
Section Order :
395